Clinical trialNCT07436728RecruitingPhase 1/PHASE2Interventional

A Study of TAK-505 in Adults With Solid Tumors

SponsorTakedaEnrollment151Malignant Solid Tumors

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Study Director
Takeda
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Uci Health
Orange, California, United States
Farshid Dayyani
Not, yet, recruiting
University of California San Diego Medical Center, la Jolla
San Diego, California, United States
Sandip Patel
Not, yet, recruiting
University of California San Francisco
San Francisco, California, United States
Bridget Keenan
Not, yet, recruiting
H Lee Moffitt Cancer Center
Tampa, Florida, United States
Tiago Biachi de Castria
Not, yet, recruiting
Univeristy of Minnesota
Minneapolis, Minnesota, United States
Nicholas Zorko
Not, yet, recruiting
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Dan Feng
Not, yet, recruiting
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Wen Wee Ma
Not, yet, recruiting
Sarah Cannon Research Institute Scri
Nashville, Tennessee, United States
Deepak Bhamidipati
Not, yet, recruiting
Tennessee Oncology
Nashville, Tennessee, United States
Jeffrey Russell
Not, yet, recruiting
Mary Crowley Cancer Center
Dallas, Texas, United States
Douglas Orr
Not, yet, recruiting
Baylor College of Medicine
Houston, Texas, United States
Benjamin Musher
Not, yet, recruiting
Md Anderson
Houston, Texas, United States
Ecaterina Dumbrava
Not, yet, recruiting
Next Oncology
San Antonio, Texas, United States
Ildefonso Rodriguez Rivera
Recruiting
Next Oncology
Fairfax, Virginia, United States
Alexander Spira
Recruiting
Seattle Cancer Care Alliance
Seattle, Washington, United States
Rafael Santana-Davila
Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

TAK-505

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 11 May 2026
Primary completion: 18 Aug 2030
Completion: 18 Aug 2030
Last update posted: 14 May 2026
Registered enrollment: 151
Registry id: NCT07436728

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.